Author Guidelines

NOWOTWORY Journal of Oncology publishes papers which cover all aspects of oncology but concentrates on clinical studies, both research orientated and treatment orientated, rather than on laboratory studies. Contributions are also welcomed from the fields of epidemiology, tumor pathology, radiobiology and radiation physics.

Journal follows editorial recommendations of International Committee of Medical Journal Editors (ICMJE) (available at http://www.icmje.org/recommendations/). Via Medica strongly recommends journal editors to adhere to the principles of Committee on Publication Ethics (COPE), particularly to deal with acts of ethical misconduct. For more information Authors, Readers and Editors may visit the COPE website: http://publicationethics.org/.

Authors statment All submitted manuscripts will be peer reviewed and the authors will be required to state that their paper has not been previously published or has been accepted for publication elsewhere, and has not simultaneously been submitted to another journal. An author statment must accompany each submitted manuscript and this letter must be signed by all authors and not only by the first author. In this letter any financial conflicts of interest must be specified. In addition, all sources of financial support for the study must be described. It is the responsibility of the main author of the paper to obtain written copyright permission for any material, text or illustrations, for which the copyright is owned by another person or persons or by an organization or by another journal.

Publication ethics and malpractice statement The Editor is responsible for everything published in the journal. The Editor takes all reasonable steps to ensure the quality of the material published. The Editor’s decision to accept or reject a paper for publication is based only on the paper’s importance, originality, clarity and the study’s relevance to the remit of the journal. The description of peer review process is published and clarified and the Editor is able and ready to justify any important deviation from the described process. The authors and peer reviewers’ identities are protected. The Editor provides guidance to authors and reviewers on everything that is expected of them. The Editor does not reverse a decision to accept a submission unless serious problems are identified. The relationship of the Editor to the publisher and owner is based firmly on the principle of editorial independence. The Editor makes decisions on which articles to publish based on quality and suitability for the journal and without interference from the journal owner/publisher.
The Editor can ensure that research material they publish conforms to internationally accepted ethical guidelines. The Editor is able to protect the confidentiality of individual information. The Editor has a duty to act if they suspect misconduct. The duty extends to both published and unpublished papers. The Editor should seek a response from those accused. If not satisfied with the response, the Editor should ask the relevant employers or some appropriate body to investigate. Editors should have systems for managing their own conflicts of interest as well as those of their staff, authors, reviewers and Editorial board members.

Human participants rights Any papers submitted which have required approval by local Ethics Committee, whether this be with regard to cancer patients within randomized or non-randomized clinical trials/studies or with regard to animal experimentation, should contain a statement to the effect that such approval has been obtained. In addition, written consent should be obtained for publication of any data or photograph, that might identify an individual patient. All procedures should be in accordance with the Helsinki Declaration.

Technical requirements for manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals prepared by the International Committee of Medical Journal Editors (the Vancouver style) — see N Eng J Med 1997; 336: 309–315 or Nowotwory 2000; 50: 64–68.

Text. The contents must be clear, accurate, coherent and logical. The text of the original paper should be divided into the following sections: Introduction, Material and Methods, Results, Discussion and Conclusions. Submit the original on-line to: redakcja@coi.waw.pl Abbreviations which are not generally accepted, should be explained when first used in the text. Footnotes should be avoided wherever possible and no paper should contain more than two footnotes.

Article

Words*

References

Figures and Tables**

Original articles

3000

30

8

Reviews

6000

100

6

Case studies

1500

15

6

Communications

1000

6

2

Varia

1000

6

2

Comments

500

5

1

Letters

500

5

2

Title page. Should contain the title, the names of all authors, the name of institution to which the article should be attributed, the name, postal and e-mail address of the corresponding author. Authorship requires substantial contributions to the development of the concept of the paper, the analysis and interpretation of data and the drafting and revision of manuscript submissions. Up to ten key words should be supplied, using terms from the medical subject headings (MeSH) list of Index Medicus.

An abstract not exceeding 150 words should be presented on a separate sheet. Abstracts of original papers should be divided into the following sections: Introduction, Material and Methods, Results, Discussion, Conclusions.

Statistics. Statistical methods must be identified and described in sufficient detail for a knowledgeable reader to be able to reproduce the statistical analysis when provided with access to the raw data. When appropriate, statistical levels of significance should be quoted, e.g. p < 0.05.

Tables. Each table should be typed double spaced on a separate sheet and must have a fully explanatory title. All tables should be numbered in order of appearance and referred to by number in the text. Place explanatory matter in notes beneath the table, not in the table legend. Tables must ne numbered using Roman numerals.

Illustrations. They should be numbered consecutively and be cited in the text. Descriptive legends for the figures should be typed in a separate list. Computer-drawn figures can be accepted only if they are of good quality. If authors wish to have their illustrations published in color, they must communicate that desire when the manuscript is submitted. The cost of color illustrations is charged to the authors. Figures can be supplied electronically so long as they are in a standard format, e.g. tiff files.

References. References must be cited as numerals in brackets in order in which they are first mentioned in the text. The titles of journals should be abbreviated according to the style used in Index Medicus. List all the authors if a paper has three or fewer authors. For more than three authors list only the first three authors followed by et al. Follow the correct style of citing references in biomedical publications prepared by the International Committee of Medical Journal Editors — see N Eng J Med 1997; 336: 309–315 or Nowotwory 1997; 47: 403–406. Note the following examples:

Journal articles: Parkin D, Clayton P, Black RF et al. Childhood leukaemia in Europe after Chernobyl. Br J Cancer 1996; 73: 1006–1012.

Chapter in a book: Philips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, (eds.) Hypertension: pathophysiology diagnosis and management. Ed. 2. New York: Raven Press; 1995, p. 465–478.

Proceedings: Bengtsson S, Solheim Bo. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, (eds.). MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 6–10 Sept. 1992; Geneva, Switzerland. Amsterdam: North-Holland; 1992, p. 1561–1565.

Author statement

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).

  2. All co-authors identified as such (if applicable) are aware of and approve the content of the manuscript, and give consent for its publication.

  3. The author(s) declare(s) that the manuscript will not be published elsewhere and in any language without prior approval of the copyright holder.

  4. The author(s) declare(s) his/her/their knowledge of the manuscript submission rules of the “Nowotwory. Journal of Oncology” journal and hereby oblige to conform to these rules.

  5. The author(s) authorize(s) the Editor to edit the submitted manuscript as necessary

  6. The reported research has been performed in compliance with the Declaration of Helsinki and local regulations regarding animal research.

  7. All sources of funding have been identified in the manuscript.

  8. All conflicts of interest have been declared by the author(s).

  9. The author(s) declare(s) that the submitted manuscript is in accordance with the instructions for ensuring a blind review. i.e., no part of the manuscript text will allow the authors to be identified by the reviewers.

Copyright Notice

Completion of the online submission form electronically is tantamount to automatically and free-of-charge transferring of the copyright for publishing and distribution of the submitted material (in all known now and developed in the future forms and fields of exploitation) to the Polish Oncological Society, under condition that those materials are accepted for publication. The authors agree not to publish any data or figures presented in their work anywhere and in any language without the prior written consent of the owner of the copyrights, i.e. Polish Oncological Society.
Legal relations between the Polish Oncological Society and the author(s) are in accordance with Polish law and with international conventions binding to Poland. The legal bases to acquiring the copyright are article 921 section copyright law and related law as well as the international conventions binding to Poland.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Nowotwory. Journal of Oncology dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl